Nuvation Bio Inc (NYSE:NUVB) Stock News, Headlines & Updates
Nuvation Bio Inc Stock News from GuruFocus
- 1
Aug 20, 2026
Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
• 8:00am
Nuvation Bio (NUVB) Gains FDA Fast Track for Safusidenib Amid High Price-to-Sales Valuation
• 7:36am
Aug 17, 2026
Aug 07, 2026
Aug 06, 2026
10-Q - Nuvation Bio Inc. (0001811063)
• 7:00pm
8-K - Nuvation Bio Inc. (0001811063)
• 7:00pm
Aug 04, 2026
Jul 22, 2026
- 1
Show
Entries
Headlines
Total 0- 1
No recent news